Skip to content

Comparison of the effect of propofol vs dexmedetomidine sedation on NIHSS score (National institute of health stroke scale) and SSEP(somatosensory evoked potential ) in patients for supratentorial tumors.

Comparison of effect of propofol vs dexmedetomidine infusion on unmasking focal neurological deficits and causing SSEP changes in supratentorial brain tumor patients undergoing neurosurgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040164
Enrollment
60
Registered
2022-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C713- Malignant neoplasm of parietal lobe Health Condition 2: C713- Malignant neoplasm of parietal lobe Health Condition 3: C712- Malignant neoplasm of temporal lobe

Interventions

Intervention1: Propofol: GABA agonist -anesthetic drug used for sedating patient to Observer Assessment Sedation score (OASS) of 4 and to observe changes in NIHSS and SSEP.Dose administered via targe

Sponsors

Sree Chitra Tirunal institute of Medical sciences and technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective supratentorial high-grade gliomas resection surgeries. 1)Age18-65years. 2)ASA grade I and II . 3)No pre operative sensory or motor neurological deficits. 4) Glasgow coma scalescore 14-15.

Exclusion criteria

Exclusion criteria: Patient refusal for study . 1)Patients with focal neurological deficits. 2)GCS score less than 14 3)Age less than 18 years and more than 60 years . 4)ASA grade III and IV . 5) Pregnant or lactating women. 6) Recurrent brain tumor. 7) Unable to communicate, comprehend or co operate during a neurological examination. 8)Impaired mental status 9) Presence of significant comorbidities like coronary artery disease, COPD, systemic hypertension, chronic renal disease. 10) Drug intake like sedatives/drugs/alcohol use.

Design outcomes

Primary

MeasureTime frame
1) Change in NIHSS scoring 2 from baseline. 2) Change in amplitude /latency in recording ssep of upper limbs.Timepoint: 1) Change in NIHSS scoring 2 from baseline. 2) Change in amplitude /latency in recording ssep of upper limbs.

Secondary

MeasureTime frame
Correlation with post op neurological deficitsTimepoint: NIHSS score recorded 3 hours following surgery

Countries

India

Contacts

Public ContactDr Manikandan S

SCTIMST,TRIVANDRUM

kanmanis@sctimst.ac.in9446334711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026